VivoSphere Launches Operations in the United Kingdom
We are pleased to share an important milestone in VivoSphere’s growth: VivoSphere UK is now beginning operations as the UK arm of US-based biotech company VivoSphere. Our UK operation is based at Colworth Science Park through a strategic partnership with MAG-AN Scientific. This development supports closer engagement with partners, clients, and research collaborators across the UK […]
Bridging the Gap Between In Vitro and In Vivo with 3D Models
The Challenge in Preclinical Research Many promising drugs fail in clinical trials due to the limitations of traditional in vitro and in vivo models. 3D cell culture models offer a solution by mimicking the complexity of human tissues more effectively. The VivoSphere™ Advantage Realistic Cell-Cell & Cell-Matrix Interactions:Replicating the natural microenvironment for better insights. Customizable […]
The Future of 3D Tissue Engineering in Drug Discovery
Introduction Traditional 2D cell cultures and animal models have long been the standard in drug discovery, but they often fail to accurately predict human responses. With advancements in 3D tissue engineering, researchers now have access to physiologically relevant models that enhance drug screening and toxicity testing. Key Advancements in 3D Tissue Engineering Improved Drug Predictability:3D […]
